Related Experiment Video
Updated: Jul 7, 2025

10:28
Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
Published on: July 24, 2019
15.2K
Prediction of Parkinson's Disease Using Machine Learning Methods.
Jiayu Zhang1, Wenchao Zhou1, Hongmei Yu1
1Department of Health Statistics, School of Public Health, Shanxi Medical University, No. 56 Xinjian South Road, Yingze District, Taiyuan 030001, China.
Biomolecules
|December 23, 2023
Summary
Early Parkinson's disease (PD) detection is crucial. Machine learning models using demographic data, clinical assessments, and polygenic risk scores accurately predict PD risk, with olfactory function being a key factor.
Area of Science:
- Neuroscience
- Computational Biology
- Medical Informatics
Background:
- Early detection of Parkinson's disease (PD) is vital for effective management.
- Current methods for PD risk prediction lack consensus on necessary data and optimal models.
Purpose of the Study:
- To develop and assess machine learning models for predicting Parkinson's disease risk.
- To identify the most impactful and accessible factors for PD risk assessment.
- To compare the performance of commonly used machine learning algorithms in PD risk prediction.
Main Methods:
- Grouped PD-associated factors by cost and accessibility.
- Developed risk prediction models using eight machine learning algorithms.
- Incorporated data incrementally, from demographic variables to invasive biomarkers.
- Utilized the Shapley Additive Explanations (SHAP) method to determine factor contributions.
Main Results:
- Models incorporating demographic variables, hospital examinations, clinical assessment, and polygenic risk scores demonstrated superior prediction performance.
- Invasive biomarkers did not significantly improve prediction accuracy.
- Penalized logistic regression (AUC 0.94, Brier score 0.08) and XGBoost were the most accurate models.
- Olfactory function and polygenic risk scores emerged as the most significant predictors.
Conclusions:
- A practical framework for PD risk assessment using accessible data and machine learning was established.
- The study highlights the efficacy of non-invasive factors and specific machine learning models for PD risk prediction.
- Further research can refine these models for earlier and more accurate PD diagnosis.
More Related Videos
Related Concept Videos
Parkinson's Disease: Overview
554
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
554
Parkinson's Disease: Treatment
274
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
274
Neural Regulation
39.5K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.5K
EPS and iPS Cells in Disease Research
2.8K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.8K

